Target
11-beta-hydroxysteroid dehydrogenase type 2
Ligand
BDBM50239606
Substrate
n/a
Meas. Tech.
ChEMBL_1666553 (CHEMBL4016349)
IC50
3500±n/a nM
Citation
 Ye, XYChen, SYWu, SYoon, DSWang, HHong, ZO'Connor, SPLi, JLi, JJKennedy, LJWalker, SJNayeem, ASheriff, SCamac, DMRamamurthy, VMorin, PEZebo, RTaylor, JRMorgan, NNPonticiello, RPHarrity, TApedo, AGolla, RSeethala, RWang, MHarper, TWSleczka, BGHe, BKirby, MLeahy, DKLi, JHanson, RLGuo, ZLi, YXDiMarco, JDScaringe, RMaxwell, BMoulin, FBarrish, JCGordon, DARobl, JA Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11?-Hydroxysteroid Dehydrogenase Type 1 Inhibitor. J Med Chem 60:4932-4948 (2017) [PubMed]  Article 
Target
Name:
11-beta-hydroxysteroid dehydrogenase type 2
Synonyms:
11-beta-hydroxysteroid dehydrogenase 2 | DHI2_RAT | Hsd11b2 | Hsd11k
Type:
PROTEIN
Mol. Mass.:
43740.05
Organism:
Rattus norvegicus
Description:
ChEMBL_735659
Residue:
400
Sequence:
MERWPWPSGGAWLLVAARALLQLLRSDLRLGRPLLAALALLAALDWLCQRLLPPPAALVVLAGAGWIALSRLARPPRLPVATRAVLITGCDTGFGKETAKKLDAMGFTVLATVLDLNGPGALELRARCSPRLKLLQMDLTKPEDISRVLEITKAHTASTGLWGLVNNAGLNMVVADVELSPVVTFRECMEVNFFGALELTKGLLPLLRHSRGRIVTVGSPAGDMPYPCLAAYGTSKAAIALLMDTFSCELLPWGIKVSIIQPGCFKTEAVTNVNLWEKRKQLLLANLPRELLQAYGEDYIEHLHGQFLNSLRMALPDLSPVVDAIIDALLAAQPRSRYYTGRGLGLMYFIHHYLPGGLRRRFLQNFFISHLLPRALRPGQPGPVHDTTQDPNPSPTVSAL
  
Inhibitor
Name:
BDBM50239606
Synonyms:
CHEMBL4080667
Type:
Small organic molecule
Emp. Form.:
C21H27NO3
Mol. Mass.:
341.444
SMILES:
OC1CN(C1)C(=O)CC1(C2CC3CC1CC(C2)[C@H]3O)c1ccccc1 |r,wD:17.21,TLB:16:15:8.9.10:12,7:8:14.16.15:10.11.12,7:8:12:14.15.17,THB:16:9:12:14.15.17,18:17:8.9.10:12,17:15:8:10.11.12,17:11:8:14.16.15,19:8:14.16.15:10.11.12,19:8:12:14.15.17,(43.24,-21.55,;43.72,-20.08,;43.03,-18.71,;44.4,-18.01,;45.1,-19.38,;44.88,-16.54,;43.63,-15.64,;46.35,-16.07,;47.49,-17.11,;48.99,-16.68,;48.98,-15.1,;50.02,-13.87,;48.67,-14.34,;48.68,-15.83,;50,-16.32,;51.4,-15.97,;50.4,-17.25,;51.42,-14.44,;52.71,-13.59,;47.48,-18.64,;46.13,-19.39,;46.12,-20.93,;47.44,-21.71,;48.79,-20.95,;48.79,-19.41,)|
Structure:
Search PDB for entries with ligand similarity: